Skip to main
Help and resources
Register
for My Account
Sign in
to My Account
Search
Australian Government
Federal Register of Legislation
Site navigation
Constitution
Acts
Legislative instruments
Notifiable instruments
Gazettes
Administrative Arrangements
Prerogative instruments
Norfolk Island
Home
Gazettes
In force
Text
Details
Downloads
Designation of Eculizumab (rmc) (Soliris) as an orphan drug - Alexion Pharmaceuticals Australasia
This item is authorised by the following title:
Therapeutic Goods Regulations 1990
Latest version
Save this title to My Account
Set up an alert
C2017G00130
02 February 2017
Legislation text
View document
Select value
Gazette
Filter active
Table of contents
Enter text to search the table of contents
Designation of Eculizumab (rmc) (Soliris) as an orphan drug - Alexion Pharmaceuticals Australasia - [Gazette]